Clincosm LogoSign in Get a demo

The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

Sponsor
Showa Inan General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00596401
Collaborator
(none)
3,000
Enrollment
1
Location
172
Actual Duration (Months)
17.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    3000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town
    Actual Study Start Date :
    Sep 1, 2007
    Actual Primary Completion Date :
    Dec 31, 2021
    Actual Study Completion Date :
    Dec 31, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    1

    HP eradication group
    2

    No eradication group
    3

    No Hp group

    Outcome Measures

    Primary Outcome Measures

    1. the annual incidence of gastric cancer in Iijima town [10 years]

    Secondary Outcome Measures

    1. The annual medical care cost in Iijima town [10 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 69 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • People who live in Iijima town at their age of 19 to 69 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Showa Inan General hospital Komagane Nagano Japan 399-4191

    Sponsors and Collaborators

    • Showa Inan General Hospital

    Investigators

    • Study Director: Akira Horiuchi, M.D., Showa Inan General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Akira Horiuchi, Digestive Disease Center, Showa Inan General Hospital
    ClinicalTrials.gov Identifier:
    NCT00596401
    Other Study ID Numbers:
    • sihp20076
    First Posted:
    Jan 17, 2008
    Last Update Posted:
    Feb 21, 2022
    Last Verified:
    Feb 1, 2022
    Additional relevant MeSH terms:
    Stomach Neoplasms

    Study Results

    No Results Posted as of Feb 21, 2022